AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 19764439
Drug: Intravenous fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous fentanyl analgesia (0.7 microg x kg(‐1) x hr(‐1) during operation, decreased to 0.5 microg x kg(‐1) x hr(‐1) next morning)
Trial: 19764439
Drug: Epidural analgesia
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural analgesia (0.4 microg x kg(‐1) x hr(‐1) fentanyl and 5 ml x hr(‐1) 1% mepivacaine during operation)
Trial: 15061241
Drug: Conjugated estrogens
RxNorm normalized name: Conjugated Estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated estrogens (CE) (0.625 mg/day)
Trial: 9551707
Drug: Atorvastatin 10
RxNorm normalized name: atorvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 10 mg every morning for 2 weeks
Trial: 9551707
Drug: Atorvastatin 10
RxNorm normalized name: atorvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 10 mg every morning with cimetidine 300 mg four times a day for 2 weeks
Trial: 2899586
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of netilmicin and metronidazole
Trial: 25592008
Drug: Lactoferrin-fortified formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactoferrin-fortified formula (38 mg/100 g milk, iron 4 mg/100 g milk)
Trial: 25592008
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no lactoferrin, iron 4 mg/100 g milk)
Trial: 12698851
Drug: Broncholytics (basic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Broncholytics (basic treatment)
Trial: 30763468
Drug: Pulsed Signal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed Signal Therapy (PST)
Trial: 27203797
Drug: N-methyl D-aspartate
RxNorm normalized name: N-methyl-D-glucamine
DrugBank: Meglumine (DB09415)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-methyl D-aspartate (NMDA) receptor antagonists
Trial: 22266741
Drug: 3 mL
RxNorm normalized name: WATER,INHL 3 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mL of hyaluronic acid (HA)
Trial: 10332444
Drug: Trazodone 50
RxNorm normalized name: traZODone 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trazodone 50 mg at bedtime
Trial: 30993684
Drug: Treatment group
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment group (n = 29) received two 75-min lessons on evaluating the credibility of online content.
Trial: 17235334
Drug: rosiglitazone 8
RxNorm normalized name: rosiglitazone 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rosiglitazone 8 mg/day for 6 months
Trial: 12480424
Drug: Single-dose azithromycin
RxNorm normalized name: Azithromycin
DrugBank: Azithromycin (DB00207)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Single-dose azithromycin (20 mg/kg bodyweight, maximum individual dose 1 g; n=65)
Trial: 12480424
Drug: 12.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12.5 mg/kg erythromycin (maximum dose 500 mg; n=63)
Trial: 9620115
Drug: Intramuscular injection
RxNorm normalized name: rabies, intramuscular injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injection of a standard trivalent influenza vaccine
Trial: 9620115
Drug: Subcutaneous injection
RxNorm normalized name: EPINEPHRINE 0.3 mg SUBCUTANEOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous injection of a standard trivalent influenza vaccine
Trial: 347112
Drug: deanol acetamidobenzoate,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: deanol acetamidobenzoate, 2.0 g/day for four weeks
Trial: 21711059
Drug: Fostamatinib 100
RxNorm normalized name: fostamatinib 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fostamatinib 100 mg twice daily
Trial: 19139013
Drug: Combined 13‐cis‐retinoic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined 13‐cis‐retinoic acid daily, alpha‐IFN twice weekly, and alpha‐tocopherol daily for 1 year
Trial: 15325237
Drug: Natural compounds
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Natural compounds collected from lactating women and their breastfeeding infants
Trial: 3098825
Drug: Intramuscular route
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular route of FSH administration
Trial: 3098825
Drug: Pulsatile subcutaneous
RxNorm normalized name: PULSATILLA PRATENSIS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsatile subcutaneous route of FSH administration
Trial: 23558840
Drug: Dexamethasone (IV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (IV 8 mg)
Trial: 12114338
Drug: Tiotropium 18
RxNorm normalized name: TIOTROPIUM 18MCG CAP,INHL,6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium 18 microg once daily via dry-powder inhaler
Trial: 12114338
Drug: Salmeterol 50
RxNorm normalized name: FLUTICAS 100/SALMETEROL 50 INHL DISK 14
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol 50 microg bid via metered-dose inhaler
Trial: 782144
Drug: Propranolol (Inderal)
RxNorm normalized name: propranolol Extended Release Oral Capsule [Inderal]
DrugBank: Propranolol (DB00571)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propranolol (Inderal) 160 mg/d
Trial: 28034981
Drug: Intravenous acetaminophen
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous acetaminophen (IVA) 1000 mg
Trial: 28034981
Drug: Oral acetaminophen
RxNorm normalized name: acetaminophen Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral acetaminophen (OA) 1000 mg
Trial: 25595413
Drug: Thoracic spinal
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thoracic spinal manipulative therapy (SMT)
Trial: 8197033
Drug: Ciprofloxacin 500
RxNorm normalized name: ciprofloxacin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin 500 mg every 12 hours (C500)
Trial: 8197033
Drug: Ciprofloxacin 750
RxNorm normalized name: ciprofloxacin 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin 750 mg every 12 hours (C750)
Trial: 8197033
Drug: Nalidixic acid
RxNorm normalized name: Nalidixic Acid
DrugBank: Nalidixic acid (DB00779)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nalidixic acid 1 g every 6 hours (NA)
Trial: 2884813
Drug: guanfacine 1-2
RxNorm normalized name: guanfacine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: guanfacine 1-2 mg
Trial: 31202690
Drug: Ritonavir-boosted darunavir
RxNorm normalized name: Darunavir
DrugBank: Darunavir (DB01264)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ritonavir-boosted darunavir 400 mg once daily
Trial: 31202690
Drug: Ritonavir-boosted lopinavir
RxNorm normalized name: lopinavir / ritonavir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ritonavir-boosted lopinavir 800 mg plus 200 mg ritonavir
Trial: 24928790
Drug: FP‐01.1 (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FP‐01.1 (150 μg/peptide dose group)
Trial: 23705536
Drug: Daily patient-applied
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily patient-applied subgingival root brushing for 14 days
Trial: 22256633
Drug: Moxibustion treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxibustion treatment (3 cones on each point, applied to Neixiyan, Dubi, and Ashi points, once every two days, 3 times per week for 6 weeks)
Trial: 22256633
Drug: Placebo moxibustion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo moxibustion treatment (placebo moxa sticker applied to the same points)
Trial: 19822595
Drug: High-dose cysteine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose cysteine (81 mg/kg per day)
Trial: 19822595
Drug: Standard dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dose cysteine (45 mg/kg per day)
Trial: 9644774
Drug: Continuous sequential
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous sequential regimen of 5 micrograms/day of estradiol and 5 mg/day of medrogestone from the 17th to the 28th day of the cycle (Group A)
Trial: 9644774
Drug: Continuous administration
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous administration of 50 micrograms/day estradiol and 5 mg/day medrogestone (Group B)
Trial: 8187428
Drug: 40, 80,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40, 80, 120, 160 or 200 mg rimexolone (Org 6216)
Trial: 3556307
Drug: Irradiation therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irradiation therapy
Trial: 3556307
Drug: Combined chemo‐irradiation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined chemo‐irradiation therapy (Adriamycin/Cyclophosphamide)
Trial: 29205286
Drug: Anamorelin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anamorelin (100 mg daily for 12 weeks)
Trial: 27127006
Drug: Avastin (bevacizumab)
RxNorm normalized name: Avastin
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Avastin (bevacizumab) in combination with Temozolomide (TMZ) and Radiotherapy
Trial: 23647914
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (normal daily life)
Trial: 18470902
Drug: Cladribine and
RxNorm normalized name: Cladribine
DrugBank: Cladribine (DB00242)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cladribine and cyclophosphamide combination
Trial: 18470902
Drug: Cyclophosphamide, vincristine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclophosphamide, vincristine, and prednisone combination
Trial: 18470902
Drug: Cladribine-containing regimens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cladribine-containing regimens (both cladribine alone and cladribine and cyclophosphamide combination)
Trial: 18470902
Drug: Cladribine alone
RxNorm normalized name: Cladribine
DrugBank: Cladribine (DB00242)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cladribine alone and cladribine and cyclophosphamide combination
Trial: 18470902
Drug: Cladribine alone,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cladribine alone, cladribine and cyclophosphamide combination, and cyclophosphamide, vincristine, and prednisone combination
Trial: 11012559
Drug: Propranolol 40
RxNorm normalized name: propranolol 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol 40 mg at 40 degrees C
Trial: 11012559
Drug: Propranolol 40
RxNorm normalized name: propranolol 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol 40 mg at 22 degrees C
Trial: 1577361
Drug: Individually matched
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Individually matched haloperidol dosage for 14 days
Trial: 1577361
Drug: Fixed doses
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed doses (10 mg and 20 mg haloperidol)
Trial: 3883868
Drug: Full-dose total
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full-dose total lymphoid irradiation (2000 rad)
Trial: 3883868
Drug: Low-dose total
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose total lymphoid irradiation (200 rad)
Trial: 26402923
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg testosterone
Trial: 24363302
Drug: Sodium nitrite
RxNorm normalized name: Sodium Nitrite
DrugBank: Nitrous acid (DB09112)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium nitrite 40 mg
Trial: 24363302
Drug: Sodium nitrite
RxNorm normalized name: Sodium Nitrite
DrugBank: Nitrous acid (DB09112)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium nitrite 80 mg
Trial: 16208798
Drug: Oral‐B 3D
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral‐B 3D Excel (3DE)
Trial: 12504934
Drug: Intravenous administration
RxNorm normalized name: intravenous administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous administration of 300 microg of Rhophylac
Trial: 12504934
Drug: Intramuscular administration
RxNorm normalized name: Japanese Encephalitis vaccine for intramuscular administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular administration of 300 microg of Rhophylac
Trial: 10900538
Drug: Paracetamol generic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol generic products (500 mg tablets)
Trial: 1516462
Drug: Cefetamet pivoxil
RxNorm normalized name: Cefetamet pivoxil
DrugBank: Cefetamet pivoxil (DB18915)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefetamet pivoxil 10 mg/kg b.i.d.
Trial: 1516462
Drug: Cefetamet pivoxil
RxNorm normalized name: Cefetamet pivoxil
DrugBank: Cefetamet pivoxil (DB18915)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefetamet pivoxil 20 mg/kg b.i.d.
Trial: 1516462
Drug: Cefaclor 10
RxNorm normalized name: cefaclor 100 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefaclor 10 mg/kg t.i.d.
Trial: 6373153
Drug: Microcrystalline hydroxyapatite
RxNorm normalized name: Microcrystalline Hydroxyapatite Concentrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Microcrystalline hydroxyapatite compound (MCHC) 6 to 8 g for 12 months
Trial: 24727160
Drug: Once-weekly 56.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-weekly 56.5 μg teriparatide for 72 weeks
Trial: 3554627
Drug: Activated charcoal
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activated charcoal suspension (105 g)
Trial: 3554627
Drug: Sorbitol-charcoal suspension
RxNorm normalized name: activated charcoal / sorbitol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sorbitol-charcoal suspension (105 g)
Trial: 23910201
Drug: Loaded miniscrew
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loaded miniscrew implants
Trial: 23910201
Drug: Unloaded miniscrew
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unloaded miniscrew implants
Trial: 14505201
Drug: Ruby laser
RxNorm normalized name: Ruby arsenic
DrugBank: Tetraarsenic tetrasulfide (DB19141)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ruby laser treatment (3 treatments given at monthly intervals)
Trial: 10872958
Drug: Doxycycline treatment
RxNorm normalized name: Doxycycline
DrugBank: Doxycycline (DB00254)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Doxycycline treatment (8.5% sustained-release biodegradable gel)
Trial: 10872958
Drug: Oral hygiene
RxNorm normalized name: HYDROGEN PEROXIDE 2.94 mL in 2.94 mL ORAL SPRAY [OROXID Forte Oral Hygiene]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral hygiene instruction/reinforcement (Control)
Trial: 9331117
Drug: Paclitaxel 175
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 175 mg/m2 plus carboplatin (AUC 6)
Trial: 7963760
Drug: Localized radiation
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Localized radiation treatment (1.8 Gy per fraction, 17 fractions)
Trial: 7963760
Drug: Localized radiation
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Localized radiation treatment
Trial: 30449208
Drug: 0.625 mg
RxNorm normalized name: estrone 0.625 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.625 mg of conjugated equine estrogen (CEE) and 100 mg of micronized progesterone (MP)
Trial: 30449208
Drug: 0.3 mg
RxNorm normalized name: biotin 0.3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg of CEE and 100 mg of MP
Trial: 30449208
Drug: 0.625 mg
RxNorm normalized name: estrone 0.625 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.625 mg of CEE and 10 mg of dydrogesterone (DDG)
Trial: 16512751
Drug: 0.2% alcohol-free
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2% alcohol-free chlorhexidine mouthrinse used twice per day for 1 week
Trial: 16512751
Drug: Placebo mouthrinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo mouthrinse used twice per day for 1 week
Trial: 8984313
Drug: Early ultrasound-guided
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early ultrasound-guided compression therapy for pseudoaneurysms, duration not specified.
Trial: 1856917
Drug: Eutectic mixture
RxNorm normalized name: brown mixture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eutectic mixture of local anesthetics (25 mg lidocaine and 25 mg prilocaine per gm)
Trial: 6349654
Drug: Meclofenamate sodium
RxNorm normalized name: Meclofenamate Sodium
DrugBank: Meclofenamic acid (DB00939)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Meclofenamate sodium (300 mg per day for one week)
Trial: 6349654
Drug: Oxyphenbutazone (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxyphenbutazone (600 mg per day)
Trial: 31711451
Drug: ROP1.3 group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ROP1.3 group (1.3 mL/kg of 0.15% ropivacaine)
Trial: 31711451
Drug: ROP1.0 group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ROP1.0 group (1.0 mL/kg of 0.15% ropivacaine)
Trial: 28957818
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg epilutein and 2 mg lutein (group 1)
Trial: 28957818
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg lutein (group 2)
Trial: 24133005
Drug: OTG3% 84
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OTG3% 84 mg/day
Trial: 18645727
Drug: Inhaled furosemide
RxNorm normalized name: Furosemide
DrugBank: Furosemide (DB00695)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled furosemide (4 ml equal to 40 mg in 10 min)
Trial: 18645727
Drug: Placebo (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (4 ml of 0.9% saline solution)
Trial: 16842467
Drug: Esomeprazole 20
RxNorm normalized name: esomeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 20 mg, rifabutin 150 mg and amoxicillin 1 g, each given b.d. for 7 days (ERA)
Trial: 16842467
Drug: Omeprazole 40
RxNorm normalized name: omeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 40 mg and amoxicillin 1000 mg, each given t.d.s. for 14 days (OA)
Trial: 1641524
Drug: Oestriol 3
RxNorm normalized name: Oestriol
DrugBank: Estriol (DB04573)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oestriol 3 mg p.o. per day for 4 weeks, followed by 1 mg per day for 8 weeks
Trial: 6361789
Drug: Aspirin 650
RxNorm normalized name: aspirin 650 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 650 mg plus codeine 60 mg
Trial: 30763195
Drug: Decolonization (chlorhexidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Decolonization (chlorhexidine mouthwash, baths or showers with chlorhexidine, and nasal mupirocin for 5 days twice per month for 6 months)
Trial: 27184521
Drug: Antipsychotic review
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antipsychotic review + social interaction
Trial: 27184521
Drug: Antipsychotic review
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antipsychotic review + exercise
Trial: 27184521
Drug: Antipsychotic review
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antipsychotic review alone
Trial: 24840143
Drug: Experimental group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental group (EG) received weekly patient progress feedback (OQ-45) and clinical support tools (CST) starting at t2.
Trial: 24840143
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (CG) received treatment-as-usual without additional feedback or tools.
Trial: 9415087
Drug: Computer-assisted learning
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Computer-assisted learning (CAL) programs in addition to daily formal teaching
Trial: 9415087
Drug: Daily formal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily formal teaching only (Control)
Trial: 29696919
Drug: Low-frequency electrical
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-frequency electrical therapy combined with rehabilitation training
Trial: 25988390
Drug: Ultrasound-guided SIJ
RxNorm normalized name: Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound-guided SIJ injection
Trial: 25988390
Drug: Fluoroscopy-guided SIJ
RxNorm normalized name: Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoroscopy-guided SIJ injection
Trial: 16874169
Drug: Pneumococcal conjugate
RxNorm normalized name: pneumococcal conjugate PCV 7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pneumococcal conjugate vaccine (not received)
Trial: 14571103
Drug: L-Carnitine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-Carnitine (2 g twice a day)
Trial: 3555129
Drug: 10 hours
RxNorm normalized name: buprenorphine
DrugBank: Buprenorphine (DB00921)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: 10 hours of daily continuous passive motion (CPM) starting on the 2nd postoperative day
Trial: 19487625
Drug: Antipsychotics (clozapine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antipsychotics (clozapine, risperidone, or olanzapine)